PHARMACEUTICALPioneering the use of milk exosomes for pharmaceutical drug innovation.
BENEFITSUniquely powerful properties of
milk-derived exosomes (mEVs)
These nanoscale vesicles, naturally found in milk, act as inherent messengers within the body, offering an exceptional and biocompatible platform for transporting therapeutic cargoes.
Can be orally administered with high bioavailability.
Bypasses the gut-blood, vascular & blood-brain barriers, penetrating tissues and cells.
Directly homes to the site of the injury or inflammation.
Delivers cargoes into cells to activate the development or healing process.
Naturally stable, capable of long-term shelf stability.
Non-immunogenic, consumed by billions daily.
“Milk exosomes contain the potential to stand as a new modality of drug delivery — with an all-natural packaging system, Tiny Cargo is poised to revolutionize peptide therapeutics”
Spencer Marsh
Chief Scientific Officer
The Tiny Cargo Company
Pure cGMP bovine milk exosomes
Available in milligram to kilogram quantities
PRODUCTSProduct Information
-
Utilizing cows milk as a natural and abundant source, our exosomes are biocompatible and highly effective.
-
Tiny Cargo Exosomes cater to diverse needs with precision and performance. Grades available are:
Cosmeceutical-grade exosomes: 1×10¹º/mg
Pharmaceutical-grade exosomes: 1×10¹²/mg
Food-grade exosomes: 1×10¹º/mg
-
From milligrams to kilograms, our production capabilities ensure accessibility and scalability for brands of any size.
-
Tailored exosome loading solutions include peptides, monoclonal antibodies and other therapeutic cargoes.
-
We offer competitive pricing without compromising quality by leveraging proprietary, scalable production techniques. Contact us for a free sample, product availability and pricing.
-
Click here to view the current regulatory status of milk exosomes in Cosmetics.
SERVICESPlatform-based
drug-loading
We provide pharmaceutical companies with access to our high-efficiency, functionality-preserving loading technology to enhance the delivery of their own therapeutic candidates.
Our expert team can collaborate with you to optimize exosome loading and accelerate your drug development pipeline.
A broad spectrum of cargoes
Tiny Cargo’s platform-based loading approach is versatile, capable of loading a wide range of therapies, weights and sizes.
Small molecules
To date, >95% loading efficiency has been achieved for a variety of small molecules
Biologics
>90% loading efficiency with biologics, including monoclonal antibodies (mAbs) up to 150 kDa achieved to date.
Peptides
>99% loading efficiency achieved for peptide therapeutics to date, including the modified αCT11 peptide in our proprietary drug, XoLacta.
Latest publications
Spencer Marsh and Rob Gourdie
We’re a team of highly experienced innovators
We are a global leader in milk exosome manufacturing (isolation), functional application into products, and the loading of exosomes with therapeutic cargoes.
Our manufacturing and our team of scientists and biotechnicians are based in Roanoke, Virginia, USA.